Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk

被引:139
作者
Wolberg, AS
Monroe, DM
Roberts, HR
Hoffman, M
机构
[1] Durham VA Med Ctr, Durham, NC 27705 USA
[2] Univ N Carolina, Ctr Thrombosis & Hemostasis, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[4] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA
[5] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
关键词
D O I
10.1182/blood-2002-08-2527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individuals with elevated prothrombin levels are at increased risk of venous thrombosis. To understand the mechanism behind this observation, we studied the effect of prothrombin concentration on thrombin generation and fibrin clot structure. The pattern of thrombin generation was directly related to the prothrombin level at all concentrations tested. From 0% to 300% of normal plasma levels of prothrombin, increasing the prothrombin concentration increased the initial rate, peak, and total amount of thrombin generated. Importantly, fibrin clot structure was also affected by the prothrombin concentration. Fibrin clots made from prothrombin concentrations less than 10% of plasma levels were weak and poorly formed. Fibrin clots made at 10% to 100% of plasma levels of prothrombin had similar fiber structures (mass-to-length ratio; mu). However, the fiber mass-to-length ratio decreased with increasing prothrombin levels more than 100% of plasma levels, in a dose-dependent manner. These results suggest that increased levels of prothrombin alter thrombin generation and clot structure. Specifically, elevated prothrombin levels produce clots with reduced fibrin mass-to-length ratios compared with normal clots. We hypothesize that this alteration in fibrin clot structure is an important determinant of the risk of thrombosis. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3008 / 3013
页数:6
相关论文
共 52 条
[1]  
Allen GA, 1999, THROMB HAEMOSTASIS, P316
[2]  
BANNINGER H, 1994, BIOCHEM J, V298, P157
[3]   FUNCTIONAL EVALUATION OF AN INHERITED ABNORMAL FIBRINOGEN - FIBRINOGEN BALTIMORE [J].
BECK, EA ;
SHAINOFF, JR ;
VOGEL, A ;
JACKSON, DP .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (09) :1874-&
[4]   FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION [J].
BLOMBACK, B ;
CARLSSON, K ;
FATAH, K ;
HESSEL, B ;
PROCYK, R .
THROMBOSIS RESEARCH, 1994, 75 (05) :521-538
[5]   Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J].
Broze, GJ ;
Higuchi, DA .
BLOOD, 1996, 88 (10) :3815-3823
[6]   Normal thrombin generation [J].
Butenas, S ;
van't Veer, C ;
Mann, KG .
BLOOD, 1999, 94 (07) :2169-2178
[7]   EFFECT OF FIBRIN STRUCTURE ON PLASMIN-MEDIATED DISSOLUTION OF PLASMA CLOTS [J].
CARR, ME ;
ALVING, BM .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) :567-573
[8]  
CARR ME, 1980, J LAB CLIN MED, V96, P985
[9]   Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma [J].
Carr, ME ;
Dent, RM ;
Carr, SL .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (01) :83-88
[10]  
CARRELL N, 1983, BLOOD, V62, P439